GenomOncology receives investment from TriStar Technology Ventures

February 5, 2014

GenomOncology, a Westlake company that has developed software platforms to automate the analysis of sequenced genetic information, said it has received an investment fromĀ TriStar Technology Ventures, a health care innovation venture firm based in Nashville, Tenn.

Welcome to To find out more about how we use cookies and how you can change your settings, read our privacy policy